| CEO Name | Prahlad Singh |
| Nationality | India |
| Net Worth Estimation | $30 million |
Prahlad Singh's estimated net worth of around $30 million stems from his executive compensation, stock holdings, and performance-based bonuses as CEO of PerkinElmer, Inc. (now Revvity, Inc.). His long tenure in the life sciences sector, including equity grants and company growth under his leadership, significantly contributes to this valuation.
Prahlad Singh, CEO of PerkinElmer, Inc. (now Revvity, Inc.), has an estimated net worth of $30,000,000, which is 37.5% of the healthcare category's maximum CEO net worth ($90,000,000). This amount also represents 300% of the minimum estimated CEO net worth ($10,000,000) in the same sector.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Prahlad Singh Performance in PerkinElmer, Inc. (now Revvity, Inc.)
Prahlad Singh, CEO of PerkinElmer, Inc. (now Revvity, Inc.), demonstrates transformative leadership by driving strategic innovation and operational excellence in life sciences and diagnostics. His decision-making emphasizes data-driven growth, portfolio expansion, and digital transformation, substantially enhancing company performance and market position. Under Singh's leadership, Revvity has achieved significant revenue growth, improved shareholder value, and strengthened its competitive edge in the global health technology sector.
Latest News
Revvity, Inc. (formerly PerkinElmer) CEO Prahlad Singh leads strong Q1 2025 growth and strategic transformation.
Revvity reported $665 million revenue in Q1 2025, with CEO Singh emphasizing its focus on life sciences and diagnostics after divesting other units. The company rebranded from PerkinElmer, consolidating its genomics, diagnostics, and research services under a unified strategy advancing from discovery to cure.
Source: http://www.stocktitan.net/news/PKI/